Top Markets
#1 Akedo Akedo +58.73%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +47.62%
#4 Velvet Velvet +38.36%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cross Cross +27.05%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.76%
#8 QANplatform QANplatform +14.60%
#9 Perle Perle +14.17%
#10 Bitway Bitway +13.96%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
Clasificación en acciones #38547
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company... BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.
Precio por acción
$0.8
Última sincronización: 2023-10-03
Capitalización bursátil
$922.40K
Cambio (1 día)
-5.88%
Cambio (1 año)
0.00%
País
IL
Comercio BiondVax Pharmaceuticals Ltd. (BVXV)

Categoría

Healthcare
Ratio P/S de BiondVax Pharmaceuticals Ltd. (BVXV)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de BiondVax Pharmaceuticals Ltd., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de BiondVax Pharmaceuticals Ltd. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE